连接社区，从多方面解决癌症问题。

Connecting communities to tackle cancer from many sides.

出版信息

Cell. 2021 Apr 15;184(8):1949-1952. doi: 10.1016/j.cell.2021.03.004. Epub 2021 Apr 7.

DOI:10.1016/j.cell.2021.03.004

Abstract

Interdisciplinary work has played a key role in Dr. Elizabeth Eisenhauer's wide-ranging research contributions and leadership in cancer clinical trials, drug delivery, treatment standards, and research and prevention strategy. Cell editor Emma Yee talked with Dr. Eisenhauer, recipient of the 2021 Canada Gairdner Wightman Award, to learn more about the factors that influenced her work in cancer care and the lessons she learned along the way. This conversation is presented below, edited for clarity and length. Note the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) was renamed the Canadian Cancer Trials Group (CCTG) in 2016. In this interview, the two are used interchangeably.

摘要

跨学科工作在伊丽莎白·艾森豪尔博士广泛的研究贡献和癌症临床试验、药物输送、治疗标准以及研究和预防策略的领导中发挥了关键作用。细胞编辑艾玛·叶（Emma Yee）与艾森豪尔博士（Elizabeth Eisenhauer）进行了交谈，她获得了 2021 年加拿大盖尔德纳·怀特曼奖（Canada Gairdner Wightman Award），以了解更多影响她癌症护理工作的因素，以及她一路走来所学到的教训。下面呈现了这次对话，经过编辑以确保清晰和简洁。请注意，加拿大国家癌症研究所临床试验组（NCIC CTG）于 2016 年更名为加拿大癌症临床试验组（CCTG）。在这次采访中，这两个组织可以互换使用。